Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03966118
Title Avelumab + Paclitaxel/ Ramucirumab (RAP) as Second Line Treatment in Gastro-esophageal Adenocarcinoma (AIO-STO-0218)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors P. C. Thuss-Patience
Age Groups: senior | adult
Covered Countries DEU

Facility Status City State Zip Country Details
Charité Universitätsmedizin Berlin Recruiting Berlin 13353 Germany Details
*Shaded cells indicate that there was no data available from for the field